Investor Presentation
Awaiting price reaction for this filing.
JB Pharma has filed an investor presentation detailing Torrent Pharmaceuticals' two-step acquisition and merger plan. Torrent will first acquire a 46.39% stake in JB Pharma for INR 11,917 crore at INR 1,600 per share via a Share Purchase Agreement, which triggers a mandatory open offer for an additional 26% at INR 1,639.18 per share. Following this, Torrent will merge with JB Pharma (Torrent as the surviving listed entity) with a swap ratio of 51 Torrent shares for every 100 JB Pharma shares. The merged entity will be India's 5th largest pharma company by secondary sales and 4th by prescriptions, with combined pro-forma revenue of INR 15,000+ crore and EBITDA of INR 4,800+ crore. Implementation is expected to take 15-18 months, subject to CCI, SEBI, stock exchange, NCLT, and shareholder approvals.
JB Pharma shareholders receive a cash exit at a premium for the initial stake sale, and the merger swap ratio offers continued exposure to a larger combined platform — though existing JB shareholders will end up as minority holders in the merged Torrent entity, with execution and regulatory risks remaining over the next 15-18 months.